FDA.reportPublic FDA data

GUAIFENESIN

Product NDC
0121-0744
11-digit product format
001210744
Labeler code
0121
Product ID
0121-0744_25a970c7-0016-4f22-9e94-1e20e1319e3e
Type
HUMAN OTC DRUG
Nonproprietary name
GUAIFENESIN
Dosage form
SOLUTION
Route
ORAL
Labeler
PAI Holdings, LLC dba PAI Pharma
Application
M012
Marketing category
OTC MONOGRAPH DRUG
Marketing start
2002-09-01
Substance
GUAIFENESIN
Active strength
100 mg/5mL
Pharmacologic classes
Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
GUAIFENESIN
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
GUAIFENESIN100 mg/5mL

Harmonized Identifiers#

Field, Values table
FieldValues
Unii495W7451VQ
Rxcui310604

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
4fe95224-f543-4dbb-9445-8cca122b48c8Product name120150609
e8718272-64cb-4436-969b-176c3067c8f4Product name120150609
106ff02a-57e1-4c4c-a307-fd582ff4e311Product name120150212

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0121-0744-04GUAIFENESIN118 mL in 1 BOTTLESOLUTION1189
0121-0744-08GUAIFENESIN237 mL in 1 BOTTLESOLUTION2379
0121-0744-16GUAIFENESIN473 mL in 1 BOTTLESOLUTION4739

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
GUAIFENESINACTIVE INGREDIENT495W7451VQGUAIFENESIN SOLUTION [PHARMACEUTICAL ASSOCIATES, INC.]2
GUAIFENESINACTIVE MOIETY495W7451VQGUAIFENESIN SOLUTION [PHARMACEUTICAL ASSOCIATES, INC.]2
ACESULFAME POTASSIUMINACTIVE INGREDIENT23OV73Q5G9GUAIFENESIN SOLUTION [PHARMACEUTICAL ASSOCIATES, INC.]2
CITRIC ACID MONOHYDRATEINACTIVE INGREDIENT2968PHW8QPGUAIFENESIN SOLUTION [PHARMACEUTICAL ASSOCIATES, INC.]2
FD&C GREEN NO. 3INACTIVE INGREDIENT3P3ONR6O1SGUAIFENESIN SOLUTION [PHARMACEUTICAL ASSOCIATES, INC.]2
FD&C RED NO. 40INACTIVE INGREDIENTWZB9127XOAGUAIFENESIN SOLUTION [PHARMACEUTICAL ASSOCIATES, INC.]2
HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)INACTIVE INGREDIENT8136Y38GY5GUAIFENESIN SOLUTION [PHARMACEUTICAL ASSOCIATES, INC.]2
SODIUM BENZOATEINACTIVE INGREDIENTOJ245FE5EUGUAIFENESIN SOLUTION [PHARMACEUTICAL ASSOCIATES, INC.]2
SODIUM CITRATEINACTIVE INGREDIENT1Q73Q2JULRGUAIFENESIN SOLUTION [PHARMACEUTICAL ASSOCIATES, INC.]2
WATERINACTIVE INGREDIENT059QF0KO0RGUAIFENESIN SOLUTION [PHARMACEUTICAL ASSOCIATES, INC.]2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0121-0744GUAIFENESIN SOLUTION [PAI HOLDINGS, LLC DBA PAI PHARMA]9Current NDC, Legacy NDC, 3 package rows20241113_c2e53fb5-2798-47c8-9285-d1077d46e629.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
310604guaiFENesin 100 MG in 5 mL Oral SolutionPSNc2e53fb5-2798-47c8-9285-d1077d46e6299
310604guaifenesin 20 MG/ML Oral SolutionSCDc2e53fb5-2798-47c8-9285-d1077d46e6299
310604guaifenesin 100 MG per 5 ML Oral SolutionSYc2e53fb5-2798-47c8-9285-d1077d46e6299
310604guaifenesin 100 MG per 5 ML Oral SyrupSYc2e53fb5-2798-47c8-9285-d1077d46e6299
310604guaifenesin 200 MG per 10 ML Oral SolutionSYc2e53fb5-2798-47c8-9285-d1077d46e6299
310604guaifenesin 300 MG per 15 ML Oral SolutionSYc2e53fb5-2798-47c8-9285-d1077d46e6299
310604guaifenesin 400 MG per 20 ML Oral SolutionSYc2e53fb5-2798-47c8-9285-d1077d46e6299

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
0121-0744-0400121074404118 mL in 1 BOTTLE (0121-0744-04) 118 ml2002-09-010000-00-00NoNoCurrent
0121-0744-0800121074408237 mL in 1 BOTTLE (0121-0744-08) 237 ml2002-09-010000-00-00NoNoCurrent
0121-0744-1600121074416473 mL in 1 BOTTLE (0121-0744-16) 473 ml2002-09-010000-00-00NoNoCurrent